The 7th edition of the Canadian Stroke Best Practice Recommendations (CSBPR) is a comprehensive summary of current evidence-based recommendations, appropriate for use by healthcare providers and system planners, and intended to drive healthcare excellence, improved outcomes and more integrated health systems. This edition includes a new module on the management of cerebral venous thrombosis (CVT). Cerebral venous thrombosis is defined as thrombosis of the veins of the brain, including the dural venous sinuses and/or cortical or deep veins. Cerebral venous thrombosis is a rare but potentially life-threatening type of stroke, representing 0.5–1.0% of all stroke admissions. The reported rates of CVT are approximately 10–20 per million and appear to be increasing over time. The risk of CVT is higher in women and often associated with oral contraceptive use and with pregnancy and the puerperium. This guideline addresses care for adult individuals who present to the healthcare system with current or recent symptoms of CVT. The recommendations cover the continuum of care from diagnosis and initial clinical assessment of symptomatic CVT, to acute treatment of symptomatic CVT, post-acute management, person-centered care, special considerations in the long-term management of CVT, including pregnancy and considerations related to CVT in special circumstances such as trauma and vaccination. This module also includes supporting materials such as implementation resources to facilitate the adoption of evidence into practice and performance measures to enable monitoring of uptake and effectiveness of recommendations.

The paper explores the integration of emotional design elements in the development of medical devices to enhance user acceptance and adherence. It emphasizes the importance of a user-centered approach, acknowledging both functional and emotional needs. The study compares two cases within healthcare design, highlighting the impact of emotional design on users' perception of medical devices. Despite the different stages of development in the two cases, both employed a higher level of refflective design, aiming to create a lasting impact on users' identity using the products.

The 2022 update of the Canadian Stroke Best Practice Recommendations (CSBPR) for Acute Stroke Management, 7th edition, is a comprehensive summary of current evidence-based recommendations, appropriate for use by an interdisciplinary team of healthcare providers and system planners caring for persons with an acute stroke or transient ischemic attack. These recommendations are a timely opportunity to reassess current processes to ensure efficient access to acute stroke diagnostics, treatments, and management strategies, proven to reduce mortality and morbidity. The topics covered include prehospital care, emergency department care, intravenous thrombolysis and endovascular thrombectomy (EVT), prevention and management of inhospital complications, vascular risk factor reduction, early rehabilitation, and end-of-life care. These recommendations pertain primarily to an acute ischemic vascular event. Notable changes in the 7th edition include recommendations pertaining the use of tenecteplase, thrombolysis as a bridging therapy prior to mechanical thrombectomy, dual antiplatelet therapy for stroke prevention,1 the management of symptomatic intracerebral hemorrhage following thrombolysis, acute stroke imaging, care of patients undergoing EVT, medical assistance in dying, and virtual stroke care. An explicit effort was made to address sex and gender differences wherever possible. The theme of the 7th edition of the CSBPR is building connections to optimize individual outcomes, recognizing that many people who present with acute stroke often also have multiple comorbid conditions, are medically more complex, and require a coordinated interdisciplinary approach for optimal recovery. Additional materials to support timely implementation and quality monitoring of these recommendations are available at www.strokebestpractices.ca.

There are several significant challenges that must be overcome for PEM fuel cell commercialization such as electrode flooding, carbon corrosion, and significant cost due to the high loading of the platinum catalyst. Thus, a new structure is proposed for the cathode catalyst support consisting of Si/TiOx core/shell nanowires with branched structures, which has the potential to reduce electrode flooding, increase stability, and dramatically reduce the required Pt loading. In this study, Pt-coated Si/TiOx core/shell nanowires with and without branches are compared. The Pt surface area on supports with branch structures was calculated to be more than 4 times larger than on supports without branch structures, while keeping the Pt loading at only about 0.1 mg/cm2 (for the samples with branched structures). SEM, XRD, AES, and TEM were used to characterize the morphologies and structures of the as-prepared samples. Branched Si/TiOx core/shell nanowire structures may be a promising catalyst support to enable commercialization of highly cost-efficient PEM fuel cells and to promote an era of clean energy usage.